Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

NCT07201519 is registered in ClinicalTrials.gov with Michael J Cavnar, MD as lead sponsor.

NCT NCT07201519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07201519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Lead sponsor
Michael J Cavnar, MD
Phase
Phase 2
Overall status
Recruiting
Start date
January 23, 2026
Completion date
February 28, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, intrahepatic cholangiocarcinoma